Moreover, BPN-14136 administration to mice that overexpressed human RBP4 specifically in adipocytes partially prevented diet-induced obesity and hepatic steatosis, most likely via lowering circulating RBP4 levels [98]. Here, RBP4 is linked to fatty liver disease.